1. AHRO : Austin Health Research Online

Mehrdad Nikfarjam

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Mehrdad Nikfarjam
Full Name
Nikfarjam, Mehrdad
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  He, Hong
Author:  Yeo, Dannel

Results 1-6 of 6 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
17-Feb-2017Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancerYeo, Dannel; Phillips, Phoebe; Baldwin, Graham S; He, Hong ; Nikfarjam, Mehrdad 
2Dec-2016Glaucarubinone combined with gemcitabine improves pancreatic cancer survival in an immunocompetent orthotopic murine modelYeo, Dannel; Huynh, Nhi; Beutler, John A; Baldwin, Graham S; He, Hong ; Nikfarjam, Mehrdad 
316-Jan-2016FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabineYeo, Dannel; He, Hong ; Patel, Oneel; Lowy, Andrew M; Baldwin, Graham S; Nikfarjam, Mehrdad 
41-Apr-2015The role of p21-activated kinases in pancreatic cancer.Yeo, Dannel; He, Hong ; Baldwin, Graham S; Nikfarjam, Mehrdad 
531-Jan-2014Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.Yeo, Dannel; Huynh, Nhi; Beutler, John A; Christophi, Christopher ; Shulkes, Arthur; Baldwin, Graham S; Nikfarjam, Mehrdad ; He, Hong 
619-Aug-2013Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.Nikfarjam, Mehrdad ; Yeo, Dannel; He, Hong ; Baldwin, Graham S; Fifis, Theodora; Costa, Patricia; Tan, Bryan; Yang, Eunice; Wen, Shu wen; Christophi, Christopher